Introduction

If you’re researching Carpenter syndrome and want to understand what causes it on a genetic basis, you’re at the right place. As a rare condition, Carpenter syndrome can be difficult to understand, especially when it comes to the roles of the RAB23 and MEGF8 genes. This article will break down the molecular basis of the condition.¹

What is carpenter syndrome?

Carpenter syndrome is a rare congenital disorder characterised by craniosynostosis, polydactyly, syndactyly, obesity, and cardiac and genital anomalies.⁴ It belongs to a group of syndromes known as acrocephalopolysyndactyly (ACPS) disorders.^1,4 Carpenter syndrome is unique in the combination of features and the genes responsible.

The disorder is inherited in an autosomal recessive pattern, which means that a child must inherit two defective gene copies (one from each parent) to present symptoms of the syndrome.⁴

What causes carpenter syndrome?

Carpenter syndrome is a rare autosomal recessive genetic disorder primarily caused by mutations in either the RAB23 or MEGF8 genes.¹ These genes are involved in embryonic development, particularly in regulating cell signalling pathways, cranial bone fusion, and limb formation.¹

• RAB23 mutations are the most commonly identified cause and are responsible for what is often termed Carpenter Syndrome Type 1. RAB23 is involved in suppressing the Hedgehog signalling pathway, a key driver of embryonic patterning²
• MEGF8 mutations, associated with Carpenter Syndrome Type 2, have a similar but downstream effect.³ MEGF8 is thought to interact with both RAB23 and components of the planar cell polarity and bone morphogenetic protein (BMP) pathways³

Both gene defects lead to abnormal cranial suture fusion (craniosynostosis), polydactyly (extra fingers or toes), obesity, and congenital heart malformations, which are typical physical features of Carpenter syndrome.¹ There’s more to explore about how these mutations disrupt human development and what this means for treatment and genetic counselling.

The role of RAB23 in carpenter syndrome

RAB23 belongs to the RAB family of small GTPases, which regulate intracellular vesicle transport.² However, its key function in development is as a negative regulator of the Hedgehog (Hh) signalling pathway, especially in vertebrate embryos.²

Typically:

• RAB23 inhibits Hh signalling when not needed⁵
• The Hh pathway is vital for cell fate determination, patterning of the neural tube, limbs, and craniofacial structures⁵

When RAB23 is mutated:

• The inhibition does not work
• This results in uncontrolled activation of the Hh pathway⁵
• Overactive Hh signalling leads to abnormal craniofacial and limb development, typically seen in Carpenter syndrome⁵

Mutations and their impact

Several loss-of-function mutations in RAB23 have been identified in affected individuals:

• Missense mutations can destabilise the protein⁶
• Nonsense mutations may lead to premature stop codons and truncated, nonfunctional proteins⁶
• Frameshift mutations often disrupt the protein’s GTP-binding domain⁶

These mutations directly disrupt RAB23’s ability to regulate the Hh pathway, causing the overgrowth of bone structures and impaired development.⁵ These disruptions are also observed in the RAB23 mice model knockouts.

The role of MEGF8 in carpenter syndrome

MEGF8 (multiple EGF-like domains) is a large transmembrane protein.³ Though less understood than RAB23, MEGF8 is known to play roles in:

• Neural tube closure
• Left-right body axis specification
• Bone morphogenesis

It is thought that MEGF8 physically interacts with RAB23, and possibly allows its activity or localisation in the cell.⁷ It is also involved in controlling the BMP and planar cell polarity (PCP) pathways, both of which are needed for tissue patterning during development.

Disruption in MEGF8 leads to similar phenotypes as RAB23 mutations, suggesting that the MEGF8–RAB23 interaction is vital in embryonic patterning/development.⁷

While both RAB23 and MEGF8 mutations can cause classic Carpenter syndrome, there are subtle differences:

• MEGF8 mutations may be more likely to result in laterality defects (e.g., situs inversus)⁷
• Some cardiac anomalies appear more frequently with MEGF8 mutations⁷

Molecular pathways involved

Hedgehog signalling pathway

• RAB23 is a key inhibitor of the Hedgehog pathway⁵
• Mutations in RAB23 = gain-of-function Hh signalling, leading to abnormal cell proliferation in craniofacial and limb development⁵

BMP pathway

• MEGF8 interacts with BMP pathway components⁷
• BMP signalling influences bone development, joint formation, and craniofacial morphogenesis⁷

PCP pathway

• MEGF8 may help maintain planar polarity, essential for symmetric development^7,8
• Disruption leads to body asymmetry, neural tube defects, and incorrect positioning of organs⁸

Diagnosis and genetic testing

Signs indicating Carpenter syndrome often appear early in a child’s development and typically include a combination of physical and developmental anomalies. One of the hallmark features is craniosynostosis, a condition where the skull bones fuse prematurely, leading to an abnormal head shape and potential pressure on the brain.^1,4 

Affected individuals may also have polydactyly (extra fingers or toes) or syndactyly (webbed or fused digits), which can vary in severity. Congenital heart defects are also common and may range from minor structural anomalies to serious conditions requiring surgical intervention.⁴ 

Many children with Carpenter syndrome present with short stature, often due to skeletal abnormalities, and may experience developmental delays, including delayed milestones in motor skills, speech, or learning.¹ However, these signs are not exclusive to Carpenter syndrome and can be seen in other syndromes involving craniosynostosis or limb anomalies. Due to this clinical overlap, molecular genetic testing is essential for a definitive diagnosis, as it allows for the identification of pathogenic mutations in the RAB23 or MEGF8 genes, confirming the condition.

Genetic testing

• Whole-exome sequencing or targeted panels can detect mutations in RAB23 and MEGF8. The entire set of protein-coding genes is sequenced to compare to a reference and diagnose mutations
• Carrier testing is recommended for family members

Genetic confirmation aids in early diagnosis, family planning, prenatal testing or preimplantation genetic diagnosis (PGD).

Treatment

There is no cure for Carpenter syndrome, but management of the condition can improve quality of life:⁴

• Surgical correction of craniosynostosis and polydactyly
• Cardiology evaluation for congenital defects
• Physiotherapy for motor delay
• Educational support for intellectual challenges

Future research

The study of RAB23 and MEGF8 continues to offer insights into not just Carpenter syndrome but also fundamental developmental biology.

Important ongoing research areas include:

• How MEGF8 facilitates RAB23 function
• Developing animal models to explore MEGF8-specific pathways (mouse knockouts)
• Identifying modifiers that affect severity
• Exploring therapeutic gene-editing techniques (e.g., CRISPR)

Summary

• Carpenter syndrome is a rare genetic disorder caused by mutations in RAB23 or MEGF8
• RAB23 suppresses the Hedgehog pathway, while MEGF8 modulates several developmental signalling networks, possibly acting upstream or in partnership with RAB23
• Mutations in either gene disrupt embryonic development, leading to craniosynostosis, polydactyly, heart defects, and other anomalies
• Genetic testing is required for an accurate diagnosis
• Management is supportive, and current research may lead to future therapies

FAQs

Is carpenter syndrome inherited?

Yes. It is inherited in an autosomal recessive pattern, meaning both parents must carry one copy of the mutated gene.

Can a child inherit carpenter syndrome if only one parent is a carrier?

No. A child must inherit two defective copies (one from each parent) to develop the syndrome.

Are there different types of carpenter syndrome?

Yes. Carpenter syndrome can result from mutations in either RAB23 or MEGF8, with subtle differences in symptoms. These are sometimes referred to as Type 1 and Type 2.

Is there a cure?

No cure currently exists, but early diagnosis and supportive treatments can manage symptoms effectively.

Can prenatal testing detect it?

Yes, if both parents are known carriers, prenatal genetic testing or PGD can be used during pregnancy or IVF to detect the condition.